Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
Genmab
KaliVir Immunotherapeutics
Beijing Biotech
IDEAYA Biosciences
Vivace Therapeutics, Inc
AstraZeneca
National Institutes of Health Clinical Center (CC)
Ohio State University
Nuvectis Pharma, Inc.
Dutch Society of Physicians for Pulmonology and Tuberculosis
A2 Biotherapeutics Inc.
National Institutes of Health Clinical Center (CC)
University of Chicago
A2 Biotherapeutics Inc.
University of Nebraska
Perspective Therapeutics
National Institutes of Health Clinical Center (CC)
VM Oncology, LLC
Dana-Farber Cancer Institute
Bristol-Myers Squibb
Brigham and Women's Hospital
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Baylor College of Medicine
Istituto Oncologico Veneto IRCCS
Memorial Sloan Kettering Cancer Center
Azienda Ospedaliera di Padova
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
University of Chicago
National and Kapodistrian University of Athens
Gruppo Oncologico Italiano di Ricerca Clinica
BridGene Biosciences Inc.
IRCCS Ospedale San Raffaele
NHS Greater Glasgow and Clyde
Second Affiliated Hospital of Guangzhou Medical University
A&G Pharmaceutical Inc.
Oslo University Hospital